Penn study finds taking semaglutide for weight management does not increase risk of depression or suicidal behavior in people without known major psychopathology
Theyre the result of decades of basic science, studying how the body regulates hunger, metabolism and energy balance. Beyond the gut: How the brain reacts to GLP-1 GLP-1 drugs are often described as gut hormones, and for good reason
Those who respond well to split dosing often cite faster initial improvement and more stable progress throughout the treatment period
Phase 2 trials published in the New England Journal of Medicine showed that patients taking the highest dose of Retatrutide lost an average of 24.2% of their total body weight over 48 weeks
The body composition substudy showed that lean mass loss was not unusually high relative to the fat being lost, which pushes back on the worry that these drugs just melt muscle
The effects of N-acetyl cysteine on nasal mucociliary clearance in healthy volunteers: a randomized, double-blind and placebo-controlled study